Enhanced tuberculosis screening using computer-aided chest X-ray and SILVAMP-LAM urine diagnosis in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial
Rachael Burke Wellcome Clinical PhD fellow, Malawi Liverpool Wellcome Trust & London School of Hygiene and Tropical Medicine Thursday 20th Oct 2022, 12.30–13.30pm BST Online or Wolfson Building Room 8, LSTM Rachael.email@example.com
Adherence to anti-tuberculosis treatment: Why’d you have to go and make things so complicated?
Helen Stagg, MA, MSc, PhD Reader in Infectious Disease Epidemiology Usher Institute, University of Edinburgh Thursday 18th August 2022, 12.30–13.30 BST Wolfson Room 8, LSTM, or virtually firstname.lastname@example.org
Identification of novel electron transport chain inhibitors and chemical validation of combination strategies against Mycobacterium tuberculosis
Laura Jeffreys, BSc, PhD Post-Doctoral Research Associate Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, LSTM, UK Thursday 21st July 2022, 12.00–13.00, Wolfson Rm 8, LSTM Laura.email@example.com
Professor Onn Min Kon is a respiratory physician and head of the tuberculosis service at Imperial College Healthcare NHS Trust. He is professor of respiratory medicine at the National Heart & Lung Institute, Imperial College London. He is chair of the UK National Multidrug-resistant Tuberculosis (MDRTB) clinical advice service.
Social and health factors associated with adverse treatment outcomes in people with MDR-TB in Sierra Leone
Dr Rashidatu Fouad Kamara
PhD candidate, Rey Juan Carlos University Madrid Associate Lecturer, College of Medicine and Allied Health Sciences, University of Sierra Leone Clinical Lead Multi Drug Resistant Tuberculosis, Lakka Hospital, Freetown, Sierra Leone Consultant World Health Emergencies, WHO